Related Experiment Videos

Nociceptin inhibits tonic nitric oxide release in the mouse isolated proximal colon

J R Menzies1, A D Corbett

  • 1School of Biological and Biomedical Sciences, Glasgow Caledonian University, Cowcaddens Road, Glasgow, UK. j.r.w.menzeis@gcal.ac.uk

Insights

Nociceptin/orphanin FQ (N/OFQ) causes mouse colon contractions by inhibiting nitric oxide (NO) release. This peptide, acting on opioid receptor-like (ORL1) receptors, influences gastrointestinal motility via NO pathways.

Area of Science:

  • Neuroscience
  • Gastroenterology
  • Pharmacology

Background:

  • Nociceptin/orphanin FQ (N/OFQ) is the endogenous ligand for the opioid receptor-like (ORL1) receptor.
  • The role of N/OFQ and nitric oxide (NO) in regulating colonic smooth muscle activity is not fully understood.

Purpose of the Study:

  • To investigate the mechanism by which N/OFQ induces contractions in the mouse proximal colon.
  • To determine the involvement of NO signaling pathways in N/OFQ-mediated colonic contractions.

Main Methods:

  • Isolated mouse proximal colon preparations were used.
  • Contractile responses to N/OFQ were measured in the presence and absence of tetrodotoxin (TTX) and Nomega-nitro-L-arginine (L-NNA).
  • The effects of NO synthase inhibition and NO donation on N/OFQ activity were examined.

Main Results:

  • N/OFQ, tetrodotoxin, and L-NNA all induced similar colonic contractions.
  • N/OFQ failed to induce further contractions when NO synthesis was inhibited by TTX or L-NNA.
  • Nociceptin did not affect colonic preparations pre-contracted with L-NNA and then relaxed with sodium nitroprusside.

Conclusions:

  • Nociceptin/orphanin FQ induces contractions in the mouse proximal colon.
  • These contractions are mediated by the inhibition of tonic, neuronal nitric oxide (NO) release.
  • N/OFQ's action on ORL1 receptors influences colonic motility through modulation of NO signaling.

Related Concept Videos